TCL Archive Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts June 14, 2013
TCL Archive Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival November 29, 2013
TCL Archive Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says September 6, 2002